- Home
- SDRL vs NVCR Comparison
SDRL vs NVCR Comparison
Compare SDRL & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SDRL | NVCR |
|---|---|---|
| Founded | 2005 | 2000 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.0B |
| IPO Year | 2018 | 2015 |
Fundamental Metrics
Financial Performance| Metric | SDRL | NVCR |
|---|---|---|
| Price | $47.97 | $16.94 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $56.00 | $28.08 |
| AVG Volume (30 Days) | 690.6K | ★ 1.7M |
| Earning Date | 05-11-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.61 | 21.79 |
| EPS | ★ 0.36 | N/A |
| Revenue | ★ $1,437,000,000.00 | $655,353,000.00 |
| Revenue This Year | $5.22 | $7.72 |
| Revenue Next Year | $16.68 | $6.74 |
| P/E Ratio | $130.58 | ★ N/A |
| Revenue Growth | 3.75 | ★ 8.28 |
| 52 Week Low | $28.10 | $9.82 |
| 52 Week High | $55.47 | $21.45 |
Technical Indicators
Market Signals| Indicator | SDRL | NVCR |
|---|---|---|
| Relative Strength Index (RSI) | 65.38 | 53.77 |
| Support Level | $46.78 | $14.84 |
| Resistance Level | $49.61 | $18.48 |
| Average True Range (ATR) | 1.83 | 0.74 |
| MACD | 0.53 | 0.16 |
| Stochastic Oscillator | 92.26 | 75.78 |
Price Performance
Historical ComparisonAbout SDRL Seadrill Limited
Seadrill Ltd is an offshore drilling contractor company. The company is engaged in providing offshore drilling services to the oil and gas industry. The primary business of the company is the ownership and operation of drillships, semi-submersible rigs, and jack-up rigs for operations in shallow to ultra-deepwater areas in both benign and harsh environments. The geographical segments of the company are the United States, Brazil, Angola, Norway, and others. The company derives maximum revenue from Brazil.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.